368 related articles for article (PubMed ID: 9798973)
21. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
[TBL] [Abstract][Full Text] [Related]
22. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
23. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
Kirchhofer D; Tschopp TB; Baumgartner HR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1098-106. PubMed ID: 7627702
[TBL] [Abstract][Full Text] [Related]
24. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
25. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
Wielders SJ; Béguin S; Hemker HC; Lindhout T
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of human factor VII activation.
Butenas S; Mann KG
Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
[TBL] [Abstract][Full Text] [Related]
28. Initiation and propagation of blood coagulation at artificial surfaces studied in a capillary flow reactor.
Blezer R; Willems GM; Cahalan PT; Lindhout T
Thromb Haemost; 1998 Feb; 79(2):296-301. PubMed ID: 9493579
[TBL] [Abstract][Full Text] [Related]
29. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Bajaj SP; Joist JH
Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
[TBL] [Abstract][Full Text] [Related]
30. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
31. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
32. Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
Graff J; von Hentig N; Misselwitz F; Kubitza D; Becka M; Breddin HK; Harder S
J Clin Pharmacol; 2007 Nov; 47(11):1398-407. PubMed ID: 17873238
[TBL] [Abstract][Full Text] [Related]
33. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
34. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
[TBL] [Abstract][Full Text] [Related]
35. The Na+ binding channel of human coagulation proteases: novel insights on the structure and allosteric modulation revealed by molecular surface analysis.
Silva FP; Antunes OA; de Alencastro RB; De Simone SG
Biophys Chem; 2006 Feb; 119(3):282-94. PubMed ID: 16288954
[TBL] [Abstract][Full Text] [Related]
36. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
Lefkovits J; Malycky JL; Rao JS; Hart CE; Plow EF; Topol EJ; Nicolini FA
J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577
[TBL] [Abstract][Full Text] [Related]
38. A pathway of coagulation on endothelial cells.
Nawroth PP; Stern DM
J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
[TBL] [Abstract][Full Text] [Related]
39. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
He R; Xiong S; He X; Liu F; Han J; Li J; He S
Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
[TBL] [Abstract][Full Text] [Related]
40. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
Versteeg HH; Spek CA; Richel DJ; Peppelenbosch MP
Oncogene; 2004 Jan; 23(2):410-7. PubMed ID: 14724569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]